Company intelligence / Profile preview

Gelomics

Brisbane / Kelvin Grove suburb, Queensland, Australiagelomics.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Gelomics has commercialized its flagship LunaX system and related products for advanced human-relevant in vitro tissue modeling. These technologies are used globally by pharmaceutical companies, CROs, academic institutions, and biotech firms to accelerate drug discovery with more predictive non-animal models. The company reports rapid expansion into over 23 international markets with a focus on ethical alternatives to animal testing.

Modalities: Device (3D cell culture platforms)Hydrogel-based drug delivery therapy (photocrosslinkable hydrogels)Biologic (enabling biologic research and development via tissue models)
Industry: Non-Drug Biotech

Partnerships

Clients include leading academic institutions, CROs, multinational pharmaceutical companies.

Beyond the preview

Go deeper on Gelomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gelomics.

Explore the full profile